Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal for Immunotherapy of Cancer|February 23, 2019
A good response of refractory mantel cell lymphoma to haploidentical CAR T cell therapy after failure of autologous CAR T cell therapyTongjuan Li, Yuanyuan Zhang, Dan Peng, et al.
Clinical and Experimental Medicine|June 25, 2025
Angioimmunoblastic T-cell lymphoma: a concise overview encompassing the pathogenetic, pathological, clinical, therapeutical characteristics, and recent advancesYan Feng, Yaxian Ma, Tongjuan Li, et al.
Biochemical and Biophysical Research Communications|March 14, 2022
Autophagy inhibitors enhance biomolecular delivery efficiency of extracellular vesiclesYuanyuan Zhang, Meijuan Huang, Lijun Jiang, et al.
Medicine|April 22, 2020
Case report: simultaneous occurrence of multiple myeloma and non-Hodgkin lymphoma treated by CAR T therapyTongjuan Li, Jiaqi Tan, Liting Chen, et al.
Frontiers in Oncology|October 31, 2022
Clinical characteristics and prognosis of 16 relapsed/refractory B-cell malignancy patients with CAR T-cell-related hyperferritinaemiaLanlan Zhou, Nanzhou Yu, Tongjuan Li, et al.
Biomed Research International|March 21, 2017
Identification of Significant Pathways Induced by PAX5 Haploinsufficiency Based on Protein-Protein Interaction Networks and Cluster Analysis in Raji Cell LineJia Gu, TongJuan Li, Lei Zhao, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2021
CAR19/22 T cell therapy in adult refractory Burkitt's lymphomaXiaoxi Zhou, Tong Ge, Tongjuan Li, et al.
Immunological Investigations|August 27, 2024
LncRNAPVT1 is Associated with Cancer-Associated Fibroblasts Proliferation Through Regulating TGF-βin Oral Squamous Cell CarcinomaZhen Meng, Tongjuan Li, Jun Li, et al.
Cancer Science|July 4, 2020
Clinical characteristics of hematological patients concomitant with COVID-19Xiaoxi Zhou, Gaoxiang Wang, Liting Chen, et al.
Journal of Cellular and Molecular Medicine|October 17, 2025
Daratumumab for CD20<sup>-</sup>CD38<sup>+</sup> Relapsed/Refractory Diffuse Large B-Cell LymphomaZeTong Hong, ZhaoYang Hong, YaXian Ma, et al.
Pageof 3